Dr. Corinne Bousquet is Research Director & PI of the "Microenvironment and Therapeutic Resistance in Pancreatic Neoplasms" team at the INSERM Cancer Research Center of Toulouse (CRCT). After completing a veterinarian degree at Toulouse Veterinarian School and then international PhD and postdoctoral programs (pharmacology, cell signaling & oncology) at the Universities of Toulouse and UCLA, she successfully joined the French research institute dedicated to medical research INSERM in 2001. Supported by competitive grants from European, French and charity programs (Transcan, INCa, Plan Cancer, ARC, label of the Ligue Nationale Contre le Cancer), since 2011 she has built her own team dedicated to the study of pancreatic cancer stroma, unique in its composition and determinant of tumor aggressiveness. The identification of crosstalk between pancreatic tumor cells and their stroma, focusing on cancer-associated fibroblasts, should reveal symbiotic vulnerabilities of interest for therapeutic targeting. In vivo (patient-derived xenograft) and in vitro preclinical (3D co-cultures using patient-derived tumor organoids and cancer-associated fibroblasts) models, are being developed, as well as omics approaches such as transcriptomics, translatomics and proteomics. She has also held leadership positions in several French and European organizations (e.g. Council Member of the European Pancreatic Club 2020-2022; Panel Evaluating Member of the Transcan-3 program 2023, of the French Ligue Nationale Contre le Cancer 2018-2025 and of the French INSERM Committee CSS2 2022-2026)